Pharmaceutical Business review

Illumina Sells Its iScan System To Gene Logic

Combined with Gene Logic’s platforms for fine mapping and individual SNP detection, the Illumina iScan system further extends Gene Logic’s industry-leading genotyping and gene expression profiling capabilities.

“Gene Logic is focused on providing high quality, validated and industry leading services to our clients. With the addition of the Illumina system, our clients can now get Illumina-based genomic and gene expression data generated with the quality, attention to detail and integrated offerings that make us the industry leaders. The Illumina system not only provides our clients with more choice but the system is integrated with our other genotyping and expression offerings. From Genome Wide Association Studies, follow-up studies and then individual SNP analysis, Gene Logic serves all these needs. As our clients’ application needs evolve we will continue develop industry leading services to meet those needs. ” says Anu Acharya, chief executive officer, Gene Logic.